These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 24829176)

  • 1. Perioperative glycaemic control in insulin-treated type 2 diabetes patients undergoing gastric bypass surgery.
    Cruijsen M; Koehestani P; Huttjes S; Leenders K; Janssen I; de Boer H
    Neth J Med; 2014 May; 72(4):202-9. PubMed ID: 24829176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An exploratory study of the effect of using high-mix biphasic insulin aspart in people with type 2 diabetes.
    Dashora U; Ashwell SG; Home PD
    Diabetes Obes Metab; 2009 Jul; 11(7):680-7. PubMed ID: 19527481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can a protocol for glycaemic control improve type 2 diabetes outcomes after gastric bypass?
    Fenske WK; Pournaras DJ; Aasheim ET; Miras AD; Scopinaro N; Scholtz S; le Roux CW
    Obes Surg; 2012 Jan; 22(1):90-6. PubMed ID: 22052198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postprandial hypoglycaemia after Roux-en-Y gastric bypass in individuals with type 2 diabetes.
    Guarino D; Moriconi D; Mari A; Rebelos E; Colligiani D; Baldi S; Anselmino M; Ferrannini E; Nannipieri M
    Diabetologia; 2019 Jan; 62(1):178-186. PubMed ID: 30315341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
    Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
    Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.
    Wenying Y; Benroubi M; Borzi V; Gumprecht J; Kawamori R; Shaban J; Shah S; Shestakova M; Ligthelm R; Valensi P;
    Curr Med Res Opin; 2009 Nov; 25(11):2643-54. PubMed ID: 19751116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basal insulin therapy strategy is superior to premixed insulin therapy in the perioperative period blood glucose management.
    Huang QX; Lou FC; Wang P; Liu Q; Wang K; Zhang L; Zhu L; Yu S; Xu H; Wang Q; Zhang Y; Hou WK
    Chin Med J (Engl); 2013 Nov; 126(21):4030-6. PubMed ID: 24229669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repaglinide plus single-dose insulin glargine: a safe regimen for low-risk type 2 diabetic patients who insist on fasting in Ramadan.
    Bakiner O; Ertorer ME; Bozkirli E; Tutuncu NB; Demirag NG
    Acta Diabetol; 2009 Mar; 46(1):63-5. PubMed ID: 18825302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of perioperative management of glycemia in severely obese diabetic patients undergoing gastric bypass surgery.
    Chuah LL; Miras AD; Papamargaritis D; Jackson SN; Olbers T; le Roux CW
    Surg Obes Relat Dis; 2015; 11(3):578-84. PubMed ID: 25863535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients.
    van der Wal PS; Draeger KE; van Iperen AM; Martini C; Aarsen M; Heine RJ
    Diabet Med; 1997 Jul; 14(7):556-63. PubMed ID: 9223393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fasting glycemia: a good predictor of weight loss after RYGB.
    Faria G; Preto J; Almeida AB; Guimarães JT; Calhau C; Taveira-Gomes A
    Surg Obes Relat Dis; 2014; 10(3):419-24. PubMed ID: 24462312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The usage of a simplified self-titration dosing guideline (303 Algorithm) for insulin detemir in patients with type 2 diabetes--results of the randomized, controlled PREDICTIVE 303 study.
    Meneghini L; Koenen C; Weng W; Selam JL
    Diabetes Obes Metab; 2007 Nov; 9(6):902-13. PubMed ID: 17924873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance.
    Jørgensen NB; Jacobsen SH; Dirksen C; Bojsen-Møller KN; Naver L; Hvolris L; Clausen TR; Wulff BS; Worm D; Lindqvist Hansen D; Madsbad S; Holst JJ
    Am J Physiol Endocrinol Metab; 2012 Jul; 303(1):E122-31. PubMed ID: 22535748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing hormonal and symptomatic responses to experimental hypoglycaemia in insulin- and sulphonylurea-treated Type 2 diabetes.
    Choudhary P; Lonnen K; Emery CJ; MacDonald IA; MacLeod KM; Amiel SA; Heller SR
    Diabet Med; 2009 Jul; 26(7):665-72. PubMed ID: 19573114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overnight CSII as supplement to oral antidiabetic drugs in type 2 diabetes.
    Parkner T; Møller MK; Chen JW; Laursen T; Jørgensen C; Smedegaard JS; Lauritzen T; Christiansen JS
    Diabetes Obes Metab; 2008 Jul; 10(7):556-63. PubMed ID: 17593233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal glucose tolerance testing after gastric bypass.
    Roslin MS; Oren JH; Polan BN; Damani T; Brauner R; Shah PC
    Surg Obes Relat Dis; 2013; 9(1):26-31. PubMed ID: 22398113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycaemic variability and hypoglycaemia are associated with C-peptide levels in insulin-treated type 2 diabetes.
    Christensen MB; Gæde P; Hommel E; Gotfredsen A; Nørgaard K
    Diabetes Metab; 2020 Feb; 46(1):61-65. PubMed ID: 30796973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of insulin detemir in clinical practice: 14-week follow-up data from type 1 and type 2 diabetes patients in the PREDICTIVE European cohort.
    Dornhorst A; Lüddeke HJ; Sreenan S; Koenen C; Hansen JB; Tsur A; Landstedt-Hallin L
    Int J Clin Pract; 2007 Mar; 61(3):523-8. PubMed ID: 17313628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substitution of night-time continuous subcutaneous insulin infusion therapy for bedtime NPH insulin in a multiple injection regimen improves counterregulatory hormonal responses and warning symptoms of hypoglycaemia in IDDM.
    Kanc K; Janssen MM; Keulen ET; Jacobs MA; Popp-Snijders C; Snoek FJ; Heine RJ
    Diabetologia; 1998 Mar; 41(3):322-9. PubMed ID: 9541173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of exogenously administered glucagon versus spontaneous endogenous counter-regulation on glycaemic recovery from insulin-induced hypoglycaemia in patients with type 2 diabetes treated with a novel glucokinase activator, AZD1656, and metformin.
    Krentz AJ; Morrow L; Petersson M; Norjavaara E; Hompesch M
    Diabetes Obes Metab; 2014 Nov; 16(11):1096-101. PubMed ID: 24909093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.